MyImmune Corporation
PrivateLast Round
Accelerator
Jul 1, 2026
Momentum
Top 10%
of companies Caplight tracks
Company Overview
MyImmune Corporation is a biotechnology company that utilizes an artificial intelligence platform to analyze adaptive immune receptor data for disease diagnosis and therapeutic development.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Medical AI, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MyImmune Corporation Comparables
Compare MyImmune Corporation with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Etcembly | 77% | |
| iRepertoire, Inc. | 76% | |
| Adaptive Biotechnologies | 73% |
MyImmune Corporation Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Jul 1, 2026 | ||||
| Pre Seed | Oct 23, 2024 |
Key People
Founding team and executive leadership
MyImmune Corporation Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MassChallenge Israel | Accelerator |
| Osaka University Venture Capital Co., Ltd. | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 184% MoM.
- Jul 1, 2026
Received funding from MassChallenge Israel.
Recent news
Latest coverage and updates
- is_developingSep 16, 2026
MyImmune Corporation is developing "AbSapien," a platform.
MyImmune Corporation Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about MyImmune Corporation's valuation, stock price, and market status.
Is MyImmune Corporation a public or private company?
MyImmune Corporation is a private company.
What is the current stock price of MyImmune Corporation?
MyImmune Corporation is a private company with no public stock price. No recent secondary market data is available.
How much is MyImmune Corporation worth (valuation)?
Valuation information for MyImmune Corporation is not publicly available.
Can I buy MyImmune Corporation stock?
MyImmune Corporation shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was MyImmune Corporation's last funding round?
Funding round information for MyImmune Corporation is not publicly available.
Who are the main investors in MyImmune Corporation?
Investor information for MyImmune Corporation is not publicly disclosed.
Will MyImmune Corporation IPO soon?
No public IPO plans have been announced for MyImmune Corporation.
How can I track MyImmune Corporation secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor MyImmune Corporation's secondary market activity and sign up for updates.